Sign In
Buy ELTP
$0.385
+0.0151 (+4.08%)
At Close: Jun 25, 2026
Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026 Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Eli
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
07:00am, Monday, 15'th Jun 2026
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufact
Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufactu
Critical Comparison: Elite Pharmaceuticals (OTCMKTS:ELTP) versus Rafael (NYSE:RFL)
02:15am, Wednesday, 08'th Apr 2026
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) and Rafael (NYSE: RFL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses
Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?
04:57am, Tuesday, 07'th Apr 2026
Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.40 and trad
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
08:00am, Thursday, 02'nd Apr 2026
Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,
Elite Pharmaceuticals (OTCMKTS:ELTP) Shares Cross Below 200-Day Moving Average – Should You Sell?
02:52am, Saturday, 28'th Mar 2026
Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shares passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.52 and
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
12:01pm, Friday, 20'th Feb 2026
ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.
Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript
07:14pm, Wednesday, 18'th Feb 2026
Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript
Conference Call Scheduled for Wednesday, February 18 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"
Financials for Third Quarter of Fiscal Year 2026 Ended December 31, 2025 will be released on Tuesday, February 17, 2026 Northvale, New Jersey--(Newsfile Corp. - February 11, 2026) - Elite Pharmaceutic
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
12:41pm, Wednesday, 19'th Nov 2025
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript
05:27pm, Monday, 17'th Nov 2025
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2026 Earnings Call November 17, 2025 11:30 AM EST Company Participants Nasrat Hakim - Chairman, CEO & President Carter Ward - CFO, Secretary & Treasurer Pre
Conference Call Scheduled for Monday, November 17 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a
Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025 Northvale, New Jersey--(Newsfile Corp. - November 10, 2025) - Elite Pharmaceuti
